Suchergebnisse - "Glomerulosclerosis, Focal Segmental"

PubPharm (160)

61

Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome : Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome Unresponsive to 8 Weeks of High Dose Prednisone

enthalten in: ClinicalTrials.gov | 2018

62

The Spectrum of Biopsy-Proven Glomerular Diseases among Children in China : A National, Cross-Sectional Survey

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2018

von Nie, S. | He, W. | Huang, T. | +10

CommentIn: Clin J Am Soc Nephrol. 2018 Jul 6;13(7):977-978. - PMID 29915130

63

Glucocorticoids in the Treatment of Glomerular Diseases : Pitfalls and Pearls

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2018

von Ponticelli, C. | Locatelli, F.

64

Evaluation of Albuminuria HIV-Infected Patients : Prospective Evaluation of Albuminuria in HIV Positive Patients

enthalten in: ClinicalTrials.gov | 2018

65

An Outcomes-Based Definition of Proteinuria Remission in Focal Segmental Glomerulosclerosis

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2018

von Troost, J. | Trachtman, H. | Nachman, P. | +11

66

Predictors of Disease Progression in Primary Focal Segmental Glomerulosclerosis : Predictors of Disease Progression in Patients With Primary Focal Segmental Glomerulosclerosis

enthalten in: ClinicalTrials.gov | 2018

67

Treating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial Effects : Treating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial Effects: "The TRANSLATE Study"

enthalten in: ClinicalTrials.gov | 2018

68

Urinary Fibrinogen as a Predictor of Progression of CKD

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2017

von Wang, H. | Zheng, C. | Lu, Y. | +5

69

Rituximab Treatment of Focal Segmental Glomerulosclerosis : Anti-CD20, Rituximab, for the Treatment of Recurrent or Primary Resistant Focal Segmental Glomerulosclerosis (FSGS)

enthalten in: ClinicalTrials.gov | 2017

70

Histopathological analysis of the non - tumour parenchyma following radical nephrectomy : can it predict renal functional outcome?

enthalten in: International braz j urol : official journal of the Brazilian Society of Urology | 2017

von Birendra, R. | John, N. | Duhli, N. | +3